Use of computationally derived protein structures of genetic polymorphisms in pharmacogenomics and clinical applications
OwnerKalyanaraman Ramnarayan, Edward Maggioinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerKalyanaraman Ramnarayan, Edward Maggioinventors
Estimating the term…
Provided herein are computer-based methods for generating and using three-dimensional (3-D) structural models of target molecules and databases containing the models. The targets can be protein structural variants derived from genes containing polymorphisms. The models are generated using molecular modeling techniques and are used in structure-based drug design studies for identifying drugs that bind to particular structural variants in structure-based drug design studies, to design allele-specific drugs and population-specific drugs and for predicting clinical responses in patients. Computer-based methods for predicting drug resistance or sensitivity via computational phenotyping are also provided. Databases containing protein structural variant models are also provided.
A computer-based method of drug design based on genetic polymorphisms, comprising:
Dependencies are inferred from the claim text.